Dogwood Therapeutics raises $12.5 million in registered direct offering Jan 12, 2026 08:33AM
Dogwood Therapeutics, Inc. Announces Financing of up to $26.8 Million to Progress Halneuron® Through Phase 2b Development Jan 12, 2026 08:30AM
Dogwood Therapeutics to Participate at the Maxim Growth Summit 2025 Oct 14, 2025 08:45AM
Dogwood Therapeutics (DWTX) Prices 579K Share Offering at $8.26/sh Mar 13, 2025 09:02AM
Dogwood Therapeutics, Inc. Announces Pricing of $4.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules Mar 13, 2025 09:00AM